Filing Flows › Carter's (CRI) › Guidance & outlook
Carter's (CRI) guidance and outlook
Carter's (CRI) raised its guidance on Oct 30, 2026: Operating cash flow $240M–$250M for FY2026; Capital expenditures $50.0M for FY2026; Interest expense $32.0M for FY2026; Tax rate 23% for FY2026. Carter's 10-Q filed Oct 30, 2026 makes 3 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Operating cash flow | FY2026 | $240M–$250M | raised |
| Capital expenditures | FY2026 | $50.0M | reaffirmed |
| Interest expense | FY2026 | $32.0M | new |
| Tax rate | FY2026 | 23% | reaffirmed |
From the earnings release filed Oct 30, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Oct 30, 2026
- The assumptions used in the quantitative impairment test of the goodwill of our reporting units include projected revenue growth and profitability, terminal growth rates, discount rates, market multiples, and applicable control premiums.
- The assumptions used in the quantitative impairment test of our indefinite-lived intangible tradename assets include projected revenue growth and profitability, terminal growth rates, discount rates, and royalty rates.
- Should these conditions lead to a significant decline in projected financial results, there could be impairment charges to these assets mentioned above, to the goodwill ascribed to our other reporting units, or to our other indefinite-lived intangible tradename assets.
Carter's latest quarter
Carter's, Q3 2026: revenue $752M (-0.7% year over year), operating margin 7.4%, net earnings $36.6M, operating cash flow −$100M. The chart follows the revenue to costs, profit and cash.
Questions
Did Carter's raise or lower its guidance?
Carter's (CRI) raised its guidance on Oct 30, 2026: Operating cash flow $240M–$250M for FY2026; Capital expenditures $50.0M for FY2026; Interest expense $32.0M for FY2026; Tax rate 23% for FY2026.
What does Carter's expect?
The assumptions used in the quantitative impairment test of the goodwill of our reporting units include projected revenue growth and profitability, terminal growth rates, discount rates, market multiples, and applicable control premiums. The assumptions used in the quantitative impairment test of our indefinite-lived intangible tradename assets include projected revenue growth and profitability, terminal growth rates, discount rates, and royalty rates. Should these conditions lead to a significant decline in projected financial results, there could be impairment charges to these assets mention
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.